Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Adding chemotherapy to radiotherapy halves risk of bladder cancer returning
Bladder cancer patients given low doses of chemotherapy combined with radiotherapy were nearly 50 per cent less likely to relapse with the most lethal form of the disease compared to patients given radiotherapy alone.
$10 million boost for efforts to personalise prostate cancer treatment
Professor Johann de Bono from The Royal Marsden and The Institute of Cancer Research (ICR) will collaborate with other leading prostate cancer researchers in a $10 million global effort to drive the development of personalised treatment for this disease.
Gene linked to oestrogen levels and breast cancer risk in younger women
Scientists have found the first direct link between breast cancer risk and genetically-determined levels of the hormone oestrogen in younger women, according to a paper published online this week in the Journal of the National Cancer Institute.
BBC documentary Horizon takes on cancer
BBC’s award winning documentary series, Horizon, will follow the work of The Royal Marsden and The Institute of Cancer Research (ICR) on Tuesday April 10 in their hour-long episode “Horizon: Defeating Cancer”.
Trials show promise of human virus to treat head and neck cancer patients
A naturally-occurring harmless human virus may be able to boost the effects of two standard chemotherapy drugs in some cancer patients, according to early stage trial data published today in Clinical Cancer Research
Scientists honoured at the AACR conference
Scientists from The Institute of Cancer Research have received several major honours at the American Association for Cancer Research annual meeting this week.
Diabetes treatment doubles skin cancer drug's effectiveness
Researchers have found that using the diabetes drug metformin with Avastin (bevacizumab) to treat skin cancer almost doubles its ability to block tumour growth, according to a study in Cancer Discovery.
Test for single genetic fault can predict child cancer patient survival
A study led by The Institute of Cancer Research (ICR) has shown that a simple genetic test could help predict the aggressiveness of rhabdomyosarcomas in children and should be introduced into clinical practice.
Team wins prestigious global award for cancer drug success
A multidisciplinary team from The Institute of Cancer Research (ICR) and The Royal Marsden Hospital, which receives funding from Cancer Research UK*, has won a prestigious global award for its success in taking new cancer drugs from concept to patients.
ICR-discovered drug abiraterone shows success in earlier-stage prostate patients
A large-scale international trial of abiraterone acetate in patients with earlier-stage prostate cancer has been stopped early due its effectiveness, so those on the placebo arm could be offered the drug.
Targeted skin cancer drug launches in UK
A life-extending pill for advanced melanoma that The Institute of Cancer Research and The Royal Marsden Hospital helped develop is now available in the UK.
Antidepressant shows promise as cancer treatment
An antidepressant combined with a drug derived from vitamin A could be used to treat a common adult form of leukaemia, according to laboratory research led by a team at the ICR.